FDA Clears DNA Test to Spot Cancer Genes, but With Warnings
WASHINGTON (AP) — U.S. regulators have approved the first direct-to-consumer breast cancer gene test. But the Food and Drug Administration said Tuesday it will require warnings about the limitations of the genetic information from California-based 23andMe. The test, which analyzes…


